蓝帆医疗(002382.SZ)：子公司Lithonic冠脉血管内冲击波治疗系统获得CE证书

Core Viewpoint - The company, Bluestar Medical (002382.SZ), announced that its subsidiary, Biosensors Interventional Technologies Pte. Ltd., has received CE certification for the Lithonic™ coronary intravascular shockwave treatment system, which is designed to treat severely calcified narrow areas in blood vessels [1] Group 1 - The Lithonic™ system is intended for use in areas where balloon dilation is insufficient or stents cannot be evenly expanded due to calcification [1] - The system operates by releasing high-pressure shockwaves to pre-treat calcified lesions, utilizing the electrolysis effect in an electrolyte solution to precisely deliver the treatment [1] - This innovative approach aims to reduce the risk of complications associated with traditional calcified lesion treatments, such as vascular perforation and no-reflow phenomena [1]